Myocardial Necrosis in a Child After COVID-19: A Case Report

Faeze Keihanian1, Hassan Mottaghi Moghaddam Shahri2, Amin Saeidinia2

  • 1Cardiology Department, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.

Clinical Case Reports
|October 20, 2025
PubMed

Insights

COVID-19 can cause rare heart attacks in children. This case highlights the need to consider coronary artery thrombosis in pediatric patients with COVID-19 and cardiac symptoms.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Cardiovascular Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) has caused significant global health issues.
  • While rare, pediatric myocardial infarction (MI) can occur.
  • COVID-19 may increase inflammation and blood clotting, potentially leading to coronary thrombosis and MI in children.

Purpose of the Study:

  • To report a rare case of ST-elevation myocardial infarction (STEMI) in a pediatric patient.
  • To investigate the link between COVID-19 and coronary artery thrombosis in children.
  • To raise awareness about potential cardiac complications of COVID-19 in pediatric populations.

Main Methods:

  • Case report of an unvaccinated 4-year-old boy.
  • Clinical presentation and diagnostic workup for STEMI.
  • Assessment of COVID-19 related hyperinflammation and hypercoagulability.

Main Results:

  • The patient developed STEMI.
  • Coronary artery thrombosis secondary to COVID-19 was identified as the cause.
  • This highlights a rare but serious complication of COVID-19 in children.

Conclusions:

  • COVID-19 can precipitate coronary artery thrombosis and MI in pediatric patients.
  • Acute coronary events should be considered in children with COVID-19 presenting with cardiac symptoms.
  • Further research is needed to understand the full spectrum of COVID-19 cardiac complications in children.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
260
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
368
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
173
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
204
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
449